Mettler Toledo (MTD) FY2025 10-K Annual Report

Filed: Feb 6, 2026
Health Care
Laboratory Analytical InstrumentsSEC EDGAR

Mettler Toledo (MTD) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 6, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

Mettler Toledo FY2025 10-K Analysis

Business Overview

  • Core business: Precision instruments and analytical equipment manufacturing for laboratory and industrial use
  • New share repurchase program authorization of $2.75 billion in November 2025, adding to $3.7 billion remaining availability
+3 more insights

Management Discussion & Analysis

  • Revenue $4.0B in 2025, up 4% YoY from $3.9B in 2024; local currency sales up 3% in 2025 and 2024
  • Gross margin 59.4% in 2025 vs 60.1% in 2024; product margin 61.1% vs 62.1%, service margin 54.4% vs 53.7%
+3 more insights

Risk Factors

  • U.S.-China geopolitical tensions causing 16% sales, 29% segment profit, 29% production exposure in China with tariff increases and supply chain risks
  • Ukraine war and Middle East conflict disrupting supply chains, increasing costs, reducing shipping capacity, and heightening global economic uncertainty
+3 more insights

Mettler Toledo FY2025 Key Financial Metrics
XBRL

Revenue

$4.0B

+4.0% YoY

Net Income

$869M

+0.7% YoY

Gross Margin

59.4%

-68bp YoY

Net Margin

21.6%

-70bp YoY

ROE

-3677.4%

-299718bp YoY

Total Assets

$3.7B

+14.6% YoY

EPS (Diluted)

$42.05

+3.9% YoY

Operating Cash Flow

$956M

-1.3% YoY

Source: XBRL data from Mettler Toledo FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Mettler Toledo

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.